Disruption of STAT3 signaling in antigen presenting cells represents a novel strategy to overcome tumor-induced antigen-specific CD4+ T-cell tolerance.

被引：0
作者：
Cheng, FD
Wang, HW
Cuenca, AG
Horna, P
Suarez, L
Brayer, J
Turkson, J
Jove, R
Sotomayor, EM
机构：
[1] H Lee Moffitt Canc Ctr, Hematol Malignancies Program, Tampa, FL USA
[2] H Lee Moffitt Canc Ctr, Mol Oncol Program, Tampa, FL USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
109
引用
收藏
页码：35A / 35A
页数：1
相关论文
共 50 条
  • [1] Cucurbitacins, a family of natural compounds that effectively disrupt Stat3 signaling in antigen-presenting cells (APCs) are promising agents to overcome tumor-induced CD4+T-cell tolerance.
    Cheng, FD
    Wang, HW
    Suarez, A
    Horna, P
    Sebti, S
    Sotomayor, EM
    BLOOD, 2005, 106 (11) : 428A - 428A
  • [2] Stat3 signaling in B-cell lymphomas determines antigen-specific T-cell priming versus T-cell tolerance.
    Cheng, FD
    Wang, HW
    Cuenca, AG
    Huang, M
    Yu, H
    Jove, R
    Sotomayor, EM
    BLOOD, 2003, 102 (11) : 107A - 107A
  • [3] Expression of a "self-"antigen by human tumor cells enhances tumor antigen-specific CD4+ T-cell function
    Touloukian, CE
    Leitner, WW
    Robbins, PF
    Li, YF
    Kang, XQ
    Lapointe, R
    Hwu, P
    Rosenberg, SA
    Restifo, NP
    CANCER RESEARCH, 2002, 62 (18) : 5144 - 5147
  • [4] Modulation of antigen-presenting cells (APCs) function by aminobisphosphonates enhances T-cell priming and prevents tumor-induced T-cell tolerance.
    Cuenca, AG
    Cheng, FD
    Wang, HW
    Trindade, I
    Green, J
    Dalton, WS
    Sotomayor, EM
    BLOOD, 2001, 98 (11) : 235A - 235A
  • [5] Role of signal transducer and activation of transcription 3 (STAT-3) in immune tolerance: Blockade of Stat3 signaling in antigen-presenting cells (APCs) breaks antigen-specific T-cell anergy.
    Cheng, FD
    Cuenca, AG
    Wang, HW
    Mei, H
    Schoenberger, S
    Hua, Y
    Jove, R
    Sotomayor, EM
    BLOOD, 2002, 100 (11) : 13A - 13A
  • [6] Imatinib mesylate (STI-571) enhances antigen-presenting cell function and overcomes tumor-induced CD4+ T-cell tolerance
    Wang, HW
    Cheng, FD
    Cuenca, A
    Horna, P
    Zheng, Z
    Bhalla, K
    Sotomayor, EM
    BLOOD, 2005, 105 (03) : 1135 - 1143
  • [7] RESPONSE OF NAIVE ANTIGEN-SPECIFIC CD4+ T-CELLS INVITRO - CHARACTERISTICS AND ANTIGEN-PRESENTING CELL REQUIREMENTS
    CROFT, M
    DUNCAN, DD
    SWAIN, SL
    JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05) : 1431 - 1437
  • [8] Lead enhances CD4+ T cell proliferation indirectly by targeting antigen presenting cells and modulating antigen-specific interactions
    Farrer, DG
    Hueber, SM
    McCabe, MJ
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2005, 207 (02) : 125 - 137
  • [9] Analysing the role of ERK MAPK signaling in tolerance and priming of antigen-specific CD4+ T cells in vitro
    Hsu, L. -H.
    Paunovic, V.
    Morton, A. M.
    Harnett, M. M.
    IMMUNOLOGY, 2011, 135 : 74 - 74
  • [10] Rescue of Notch-1 Signaling in Antigen-Specific CD8+ T Cells Overcomes Tumor-Induced T-cell Suppression and Enhances Immunotherapy in Cancer
    Sierra, Rosa A.
    Thevenot, Paul
    Raber, Patrick L.
    Cui, Yan
    Parsons, Chris
    Ochoa, Augusto C.
    Trillo-Tinoco, Jimena
    Del Valle, Luis
    Rodriguez, Paulo C.
    CANCER IMMUNOLOGY RESEARCH, 2014, 2 (08) : 800 - 811
12345